Nicotinamide Riboside Supplement for MDS
Treatments studied
Part of Blood & lymphatic clinical trials.
This trial tests whether a supplement called nicotinamide riboside can help people with a blood disorder called MDS (myelodysplastic syndrome) or early warning signs of it. The supplement is meant to support your bone marrow's ability to make healthy blood cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have MDS (lower-risk type) or high-risk early warning signs (CCUS)
- You must be 18 years or older and able to follow all study procedures
- Your kidneys must work adequately (creatinine clearance ≥ 30 mL/min)
- Your liver function must be adequate (specific liver enzyme levels within limits)
- You cannot eat grapefruit, Seville oranges, or star fruit during the study
- You must not be pregnant, planning pregnancy, or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares three different medicines to see which works best for people with a blood condition called myelodysplasia (also called MDS) that causes anemia. It aims to find the safest and most effective option to improve blood counts and reduce symptoms like tiredness or shortness of breath.
This trial studies whether a supplement called nicotinamide riboside (a vitamin-like product) can be given safely during allogeneic bone marrow transplant. It may help researchers understand how well it works and how it affects recovery for people getting a donor transplant.
This trial tests whether a supplement called nicotinamide riboside (NR) can help people with rare forms of parkinsonism (PSP, MSA, or CBS). It is a double-blind study, meaning neither you nor the doctors will know if you are getting the real supplement or a placebo.
This trial tests a pill called roxadustat to help treat anemia in people with myelodysplastic syndromes (MDS). It might reduce the need for blood transfusions and improve energy levels.
This Phase 2 trial studies whether a vitamin-like supplement called nicotinamide riboside can slow or improve disability in progressive multiple sclerosis. It may help people whose symptoms have been steadily getting worse over the last 2 years.
This trial tests an experimental drug called BL-M11D1 for people with myelodysplastic syndromes (MDS) that has come back or not improved with standard treatment. The drug targets a protein called CD33 on cancer cells and may help reduce the number of abnormal cells in the bone marrow.
Hear when a new Clonal Cytopenia of Undetermined Significance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.